On 11 March 2020, WHO officially declared the rapidly spreading COVID-19 outbreak as a pandemic. The first in years, this pandemic caused the world to change its social behaviours in just a few weeks. Now, living in a post-COVID-19 society, several industries have been forced to stress test the capabilities of their remote work environment. The clinical trials industry is no exception. As a result, ideas that were once touted as ‘next generation’ during keynotes just a few years ago are now being put to the test in live trial environments. However, it’s not just the ‘shiny and new’ technologies on the front lines of post- COVID-19 trials. Instead, it’s a unique blend of eClinical technologies, new and old. This mix, combined with strong processes and quick thinking, has helped lay the foundation for our industry’s rapid pivot towards remote work.
|